NCT01531452View on ClinicalTrials.gov

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

June 30, 2013

Conditions
Stomach Neoplasms
Interventions
DRUG

Oxaliplatin

130mg/m2 d1,repeated q21d

DRUG

s1

80mg/m2/d, d1-14,repeated q21d

Trial Locations (1)

100021

cancer hospital & Institute,Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT01531452 - The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | Biotech Hunter | Biotech Hunter